drugset / Trial / NCT00377598
Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of TAK-583, once daily (QD), in relieving pain in subjects with postherpetic neuralgia.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-583 | Unknown | 5 mg | Oral |
| Subject | TAK-583 | Unknown | 25 mg | Oral |
| Subject | TAK-583 | Unknown | 50 mg | Oral |
| Subject | TAK-583 | Unknown | 100 mg | Oral |